Literature DB >> 11576589

An odd measure of risk: use and misuse of the odds ratio.

W L Holcomb1, T Chaiworapongsa, D A Luke, K D Burgdorf.   

Abstract

OBJECTIVE: To determine how often the odds ratio, as used in clinical research of obstetrics and gynecology, differs substantially from the risk ratio estimate and to assess whether the difference in these measures leads to misinterpretation of research results.
METHODS: Articles from 1998 through 1999 in Obstetrics & Gynecology and the American Journal of Obstetrics and Gynecology were searched for the term "odds ratio." The key odds ratio in each article was identified, and, when possible, an estimated risk ratio was calculated. The odds ratios and the estimated risk ratios were compared quantitatively and graphically.
RESULTS: Of 151 studies using odds ratios, 107 were suitable to estimate a risk ratio. The difference between the odds ratio and the estimated risk ratio was greater than 20% in 47 (44%) of these articles. An odds ratio appears to magnify an effect compared with a risk ratio. In 39 (26%) articles the odds ratio was interpreted as a risk ratio without explicit justification.
CONCLUSION: The odds ratio is frequently used, and often misinterpreted, in the current literature of obstetrics and gynecology.

Mesh:

Year:  2001        PMID: 11576589     DOI: 10.1016/s0029-7844(01)01488-0

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  22 in total

1.  Against all odds? Improving the understanding of risk reporting.

Authors:  Christine A'Court; Richard Stevens; Carl Heneghan
Journal:  Br J Gen Pract       Date:  2012-03       Impact factor: 5.386

2.  Use of preventive care by elderly male veterans receiving care through the Veterans Health Administration, Medicare fee-for-service, and Medicare HMO plans.

Authors:  Salomeh Keyhani; Joseph S Ross; Paul Hebert; Cornelia Dellenbaugh; Joan D Penrod; Albert L Siu
Journal:  Am J Public Health       Date:  2007-10-30       Impact factor: 9.308

3.  A Most Odd Ratio:: Interpreting and Describing Odds Ratios.

Authors:  Alexander Persoskie; Rebecca A Ferrer
Journal:  Am J Prev Med       Date:  2016-09-14       Impact factor: 5.043

4.  Evaluating Public Health Interventions: 6. Modeling Ratios or Differences? Let the Data Tell Us.

Authors:  Donna Spiegelman; Tyler J VanderWeele
Journal:  Am J Public Health       Date:  2017-07       Impact factor: 9.308

5.  Controversy and Debate: Questionable utility of the relative risk in clinical research: Paper 2: Is the Odds Ratio "portable" in meta-analysis? Time to consider bivariate generalized linear mixed model.

Authors:  Mengli Xiao; Yong Chen; Stephen R Cole; Richard F MacLehose; David B Richardson; Haitao Chu
Journal:  J Clin Epidemiol       Date:  2021-08-09       Impact factor: 6.437

6.  Limitations of Only Reporting the Odds Ratio in the Age of Precision Medicine: A Deterministic Simulation Study.

Authors:  Avishek Chatterjee; Henry Woodruff; Guangyao Wu; Philippe Lambin
Journal:  Front Med (Lausanne)       Date:  2021-05-14

7.  Effect size reporting among prominent health journals: a case study of odds ratios.

Authors:  Brian Chu; Michael Liu; Eric C Leas; Benjamin M Althouse; John W Ayers
Journal:  BMJ Evid Based Med       Date:  2020-12-10

8.  Misuse of odds ratios in obesity literature: an empirical analysis of published studies.

Authors:  Gabriel S Tajeu; Bisakha Sen; David B Allison; Nir Menachemi
Journal:  Obesity (Silver Spring)       Date:  2012-03-22       Impact factor: 5.002

9.  Large air pressure changes triggered by P-SV ground motion in a cave in northern Taiwan.

Authors:  Chieh-Hung Chen; Yang-Yi Sun; Li-Ching Lin; Peng Han; Huai-Zhong Yu; XueMin Zhang; Chi-Chia Tang; Chun-Rong Chen; Horng-Yuan Yen; Cheng-Horng Lin; Jann-Yenq Liu; Ching-Ren Lin
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

10.  Understanding of statistical terms routinely used in meta-analyses: an international survey among researchers.

Authors:  Michael N Mavros; Vangelis G Alexiou; Konstantinos Z Vardakas; Matthew E Falagas
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.